Class ITerminatedD-0145-2024
Drug recall · December 6, 2023
VITRAKVI recall
Why: Microbial Contamination of Non-Sterile Products: microbial contamination identified as Penicillium brevicompactum observed during routine ongoing stability testing
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
VITRAKVI (larotractenib) oral solution, 20mg/mL, 100 mL bottle, Rx only, Manufactured for Bayer HealthCare Pharmaceuticals Inc., Whippany, NJ 07981. NDC 50419-392-01
- Lots / codes
Lot# 2114228, EXP. 02/29/2024
- Quantity
- 192 bottles
- Company
- Bayer Healthcare Pharmaceuticals Inc., Whippany, NJ
- Distribution
- Product was distributed to specialty pharmacies and distributors nationwide who may have further distributed the product.
- Initiated
- November 6, 2023 · Voluntary: Firm initiated
- Classified
- December 7, 2023
- Reported
- December 6, 2023
- Ended
- May 29, 2024
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.